{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:54:09Z","timestamp":1794732849266,"version":"4.9.1"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell surface transmembrane receptor from the TREM receptor family, predominantly expressed on the microglia in the central nervous system (CNS). TREM2-initiated signaling plays a crucial role in regulating neuroinflammation and neurodegeneration, particularly in the context of neurodegenerative diseases such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), through the activation of downstream signaling pathways and transcriptional regulation of relevant genes. In this review, we aim to provide a concise review of the role and mechanistic implications of TREM2 in neurodegeneration and neuroinflammation, with a specific focus on AD and PD. We will discuss the most recent preclinical studies to highlight current advancements in the field. This review is intended to support both basic researchers and clinicians by enhancing their understanding of microglial function in the pathophysiology of AD and PD, as well as its role in neuroinflammation and neurodegeneration. Ultimately, we hope this contribution will pave the way for new discoveries and the development of potential therapeutic interventions.<\/jats:p>","DOI":"10.1038\/s41380-026-03505-7","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:19:49Z","timestamp":1772788789000},"page":"3978-3986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["TREM2 in neurodegeneration and diseases"],"prefix":"10.1038","volume":"31","author":[{"given":"Altaf A.","family":"Abdulkhaliq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glowi","family":"Alasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonglee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johra","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3667-2605","authenticated-orcid":false,"given":"Amir","family":"Ajoolabady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa Mohammad","family":"Yousof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Borai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-9187","authenticated-orcid":false,"given":"Bahauddeen M.","family":"Alrfaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Pratico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"3505_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8:267.","journal-title":"Signal Transduct Target Ther"},{"key":"3505_CR2","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41380-023-02399-z","volume":"29","author":"S Levi","year":"2024","unstructured":"Levi S, Ripamonti M, Moro AS, Cozzi A. Iron imbalance in neurodegeneration. Mol Psychiatry. 2024;29:1139\u201352.","journal-title":"Mol Psychiatry"},{"key":"3505_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/cm.21812","volume":"81","author":"M Goedert","year":"2024","unstructured":"Goedert M, Crowther RA, Scheres SH, Spillantini MG. Tau and neurodegeneration. Cytoskeleton. 2024;81:95\u2013102.","journal-title":"Cytoskeleton"},{"key":"3505_CR4","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.4103\/1673-5374.392879","volume":"19","author":"MF Ruitenberg","year":"2024","unstructured":"Ruitenberg MF. Cognition and movement in neurodegenerative disorders: a dynamic duo. Neural Regen Res. 2024;19:2101\u20132.","journal-title":"Neural Regen Res"},{"key":"3505_CR5","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.3390\/ijms19103082","volume":"19","author":"H Chi","year":"2018","unstructured":"Chi H, Chang H-Y, Sang T-K. Neuronal cell death mechanisms in major neurodegenerative diseases. Int J Mol Sci. 2018;19:3082.","journal-title":"Int J Mol Sci"},{"key":"3505_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","volume":"14","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA. Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med. 2010;14:457\u201387.","journal-title":"J Cell Mol Med"},{"key":"3505_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00702-009-0240-y","volume":"116","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA. Recent advances in our understanding of neurodegeneration. J Neural Transm. 2009;116:1111\u201362.","journal-title":"J Neural Transm"},{"key":"3505_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.pathol.1.110304.100113","volume":"1","author":"DM Skovronsky","year":"2006","unstructured":"Skovronsky DM, Lee VM-Y, Trojanowski JQ. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol Mech Dis. 2006;1:151\u201370.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"3505_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1198216","volume":"14","author":"S Brunelli","year":"2023","unstructured":"Brunelli S, Giannella E, Bizzaglia M, De Angelis D, Sancesario GM. Secondary neurodegeneration following Stroke: what can blood biomarkers tell us? Front Neurol. 2023;14:1198216.","journal-title":"Front Neurol"},{"key":"3505_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/alcalc\/agn079","volume":"44","author":"FT Crews","year":"2009","unstructured":"Crews FT, Nixon K. Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol. 2009;44:115\u201327.","journal-title":"Alcohol Alcohol"},{"key":"3505_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2174\/1570159X13666150122224158","volume":"13","author":"NE Savaskan","year":"2015","unstructured":"Savaskan NE, Fan Z, Broggini T, Buchfelder M, Eyupoglu IY. Neurodegeneration in the brain tumor microenvironment: Glutamate in the limelight. Curr Neuropharmacol. 2015;13:258\u201365.","journal-title":"Curr Neuropharmacol"},{"key":"3505_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1517\/13543784.10.5.985","volume":"10","author":"W Danysz","year":"2001","unstructured":"Danysz W. Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspects. Expert Opin Investig Drugs. 2001;10:985\u20139.","journal-title":"Expert Opin Investig Drugs"},{"key":"3505_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6547248","volume":"2016","author":"D Limongi","year":"2016","unstructured":"Limongi D, Baldelli S. Redox imbalance and viral infections in neurodegenerative diseases. Oxid Med Cell Longev. 2016;2016:6547248.","journal-title":"Oxid Med Cell Longev"},{"key":"3505_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186:693\u2013714.","journal-title":"Cell"},{"key":"3505_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1370580","volume":"16","author":"BM Kelser","year":"2024","unstructured":"Kelser BM, Teichner EM, Subtirelu RC, Hoss KN. A review of proposed mechanisms for neurodegenerative disease. Front Aging Neurosci. 2024;16:1370580.","journal-title":"Front Aging Neurosci"},{"key":"3505_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/antiox12010094","volume":"12","author":"C Angeloni","year":"2022","unstructured":"Angeloni C, Malaguti M, Prata C, Freschi M, Barbalace MC, Hrelia S. Mechanisms underlying neurodegenerative disorders and potential neuroprotective activity of agrifood by-products. Antioxidants. 2022;12:94.","journal-title":"Antioxidants"},{"key":"3505_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/648740","volume":"2014","author":"A Xie","year":"2014","unstructured":"Xie A, Gao J, Xu L, Meng D. Shared mechanisms of neurodegeneration in Alzheimer\u2019s disease and Parkinson\u2019s disease. Biomed Res Int. 2014;2014:648740.","journal-title":"Biomed Res Int"},{"key":"3505_CR18","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1002\/ana.410440705","volume":"44","author":"DP Perl","year":"1998","unstructured":"Perl DP, Warren CO, Calne D. Alzheimer\u2019s disease and Parkinson\u2019s disease: distinct entities or extremes of a spectrum of neurodegeneration? Ann Neurol. 1998;44:S19\u2013S31.","journal-title":"Ann Neurol"},{"key":"3505_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.724158","volume":"9","author":"J Khan","year":"2021","unstructured":"Khan J, Rudrapal M, Bhat EA, Ali A, Alaidarous M, Alshehri B, et al. Perspective insights to bio-nanomaterials for the treatment of neurological disorders. Front Bioeng Biotechnol. 2021;9:724158.","journal-title":"Front Bioeng Biotechnol"},{"key":"3505_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"R Rajmohan","year":"2017","unstructured":"Rajmohan R, Reddy PH. Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons. J Alzheimer\u2019s Dis. 2017;57:975\u201399.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"3505_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fnins.2019.00659","volume":"13","author":"X-Q Chen","year":"2019","unstructured":"Chen X-Q, Mobley WC. Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species. Front Neurosci. 2019;13:659.","journal-title":"Front Neurosci"},{"key":"3505_CR22","doi-asserted-by":"publisher","first-page":"S611","DOI":"10.3233\/JAD-179935","volume":"64","author":"W Gulisano","year":"2018","unstructured":"Gulisano W, Maugeri D, Baltrons MA, F\u00e0 M, Amato A, Palmeri A, et al. Role of amyloid-\u03b2 and tau proteins in Alzheimer\u2019s disease: confuting the amyloid cascade. J Alzheimer\u2019s Dis. 2018;64:S611\u2013S31.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"3505_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2165\/00002512-200421100-00001","volume":"21","author":"GM Bishop","year":"2004","unstructured":"Bishop GM, Robinson SR. Physiological roles of amyloid-\u03b2 and implications for its removal in Alzheimer\u2019s disease. Drugs Aging. 2004;21:621\u201330.","journal-title":"Drugs Aging"},{"key":"3505_CR24","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"G-f Chen","year":"2017","unstructured":"Chen G-f, Xu T-h, Yan Y, Zhou Y-r, Jiang Y, Melcher K, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38:1205\u201335.","journal-title":"Acta Pharmacol Sin"},{"key":"3505_CR25","doi-asserted-by":"publisher","first-page":"340ra372","DOI":"10.1126\/scitranslmed.aaf1059","volume":"8","author":"DKV Kumar","year":"2016","unstructured":"Kumar DKV, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, et al. Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease. Sci Transl Med. 2016;8:340ra372\u2013340ra372.","journal-title":"Sci Transl Med"},{"key":"3505_CR26","doi-asserted-by":"crossref","unstructured":"Olisah MC, Meludu SC, Dioka C Effect of formaldehyde exposure on oxidative stress markers, liver and kidneys of medical students during dissection in gross anatomy laboratory. Scicom J Med Appl Med Sci 2021; 1.","DOI":"10.54117\/sjmams.v1i1.4"},{"key":"3505_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","volume":"20","author":"S-S Yoon","year":"2012","unstructured":"Yoon S-S, Jo SA. Mechanisms of amyloid-\u03b2 peptide clearance: potential therapeutic targets for Alzheimer\u2019s disease. Biomol Ther. 2012;20:245.","journal-title":"Biomol Ther"},{"key":"3505_CR28","first-page":"007","volume":"1","author":"S Wang","year":"2016","unstructured":"Wang S, Mims PN, Roman RJ, Fan F. Is beta-amyloid accumulation a cause or consequence of Alzheimer\u2019s disease? J Alzheimer\u2019s Parkinsonism Dementia. 2016;1:007.","journal-title":"J Alzheimer\u2019s Parkinsonism Dementia"},{"key":"3505_CR29","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/ar.21018","volume":"292","author":"R Pluta","year":"2009","unstructured":"Pluta R, U\u0142amek M, Jab\u0142o\u0144ski M. Alzheimer\u2019s mechanisms in ischemic brain degeneration. Anat Rec: Advances in Integrative Anatomy and Evolutionary Biology: Advances in Integrative Anatomy and Evolutionary Biology. 2009;292:1863\u201381.","journal-title":"Anat Rec: Advances in Integrative Anatomy and Evolutionary Biology: Advances in Integrative Anatomy and Evolutionary Biology"},{"key":"3505_CR30","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci. 1998;95:6469\u201373.","journal-title":"Proc Natl Acad Sci"},{"key":"3505_CR31","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397:2284\u2013303.","journal-title":"Lancet"},{"key":"3505_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, et al. Trial of cinpanemab in early Parkinson\u2019s disease. N Engl J Med. 2022;387:408\u201320.","journal-title":"N Engl J Med"},{"key":"3505_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","volume":"44","author":"GE V\u00e1zquez-V\u00e9lez","year":"2021","unstructured":"V\u00e1zquez-V\u00e9lez GE, Zoghbi HY. Parkinson\u2019s disease genetics and pathophysiology. Annu Rev Neurosci. 2021;44:87\u2013108.","journal-title":"Annu Rev Neurosci"},{"key":"3505_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","volume":"21","author":"D Weintraub","year":"2022","unstructured":"Weintraub D, Aarsland D, Chaudhuri KR, Dobkin RD, Leentjens AF, Rodriguez-Violante M, et al. The neuropsychiatry of Parkinson\u2019s disease: advances and challenges. Lancet Neurol. 2022;21:89\u2013102.","journal-title":"Lancet Neurol"},{"key":"3505_CR35","first-page":"829207","volume":"2012","author":"D Protter","year":"2012","unstructured":"Protter D, Lang C, Cooper AA. \u03b1Synuclein and mitochondrial dysfunction: A pathogenic partnership in Parkinson\u2019s disease? Parkinson\u2019s Dis. 2012;2012:829207.","journal-title":"Parkinson\u2019s Dis"},{"key":"3505_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.parkreldis.2006.12.014","volume":"13","author":"T Ziemssen","year":"2007","unstructured":"Ziemssen T, Reichmann H. Non-motor dysfunction in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2007;13:323\u201332.","journal-title":"Parkinsonism Relat Disord"},{"key":"3505_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/jpm12020144","volume":"12","author":"MN Han","year":"2022","unstructured":"Han MN, Finkelstein DI, McQuade RM, Diwakarla S. Gastrointestinal dysfunction in Parkinson\u2019s disease: current and potential therapeutics. J Pers Med. 2022;12:144.","journal-title":"J Pers Med"},{"key":"3505_CR38","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/biom13040682","volume":"13","author":"N Zhao","year":"2023","unstructured":"Zhao N, Zhang Q, Yu F, Yao X, Liu H. The \u03b1-Synuclein monomer may have different misfolding mechanisms in the induction of \u03b1-Synuclein Fibrils with different polymorphs. Biomolecules. 2023;13:682.","journal-title":"Biomolecules"},{"key":"3505_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E. The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci. 2013;14:38\u201348.","journal-title":"Nat Rev Neurosci"},{"key":"3505_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.690293","volume":"13","author":"NdO Manzanza","year":"2021","unstructured":"Manzanza NdO, Sedlackova L, Kalaria RN. Alpha-synuclein post-translational modifications: implications for pathogenesis of lewy body disorders. Front Aging Neurosci. 2021;13:690293.","journal-title":"Front Aging Neurosci"},{"key":"3505_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neulet.2017.08.006","volume":"663","author":"V Nikoletopoulou","year":"2018","unstructured":"Nikoletopoulou V, Tavernarakis N. The PMR1 pump in alpha-synuclein toxicity and neurodegeneration. Neurosci Lett. 2018;663:66\u201371.","journal-title":"Neurosci Lett"},{"key":"3505_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Fari\u00f1as I, Choi-Lundberg D, Ho WH, Castillo PE, et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000;25:239\u201352.","journal-title":"Neuron"},{"key":"3505_CR43","first-page":"1","volume":"10","author":"MM Asl","year":"2019","unstructured":"Asl MM, Vahabie A-H, Valizadeh A. Dopaminergic modulation of synaptic plasticity, its role in neuropsychiatric disorders, and its computational modeling. Basic Clin Neurosci. 2019;10:1.","journal-title":"Basic Clin Neurosci"},{"key":"3505_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","volume":"75","author":"A Recasens","year":"2014","unstructured":"Recasens A, Dehay B, Bov\u00e9 J, Carballo\u2010Carbajal I, Dovero S, P\u00e9rez\u2010Villalba A, et al. Lewy body extracts from Parkinson disease brains trigger \u03b1\u2010synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol. 2014;75:351\u201362.","journal-title":"Ann Neurol"},{"key":"3505_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105760","volume":"177","author":"S Negi","year":"2024","unstructured":"Negi S, Khurana N, Duggal N. The misfolding mystery: \u03b1-syn and the pathogenesis of Parkinson\u2019s disease. Neurochem Int. 2024;177:105760.","journal-title":"Neurochem Int"},{"key":"3505_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, et al. \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4:160\u20134.","journal-title":"Nat Cell Biol"},{"key":"3505_CR47","doi-asserted-by":"publisher","first-page":"49071","DOI":"10.1074\/jbc.M208046200","volume":"277","author":"M Hasegawa","year":"2002","unstructured":"Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VM-Y, et al. Phosphorylated \u03b1-synuclein is ubiquitinated in \u03b1-synucleinopathy lesions. J Biol Chem. 2002;277:49071\u20136.","journal-title":"J Biol Chem"},{"key":"3505_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41531-023-00552-7","volume":"9","author":"DL Price","year":"2023","unstructured":"Price DL, Khan A, Angers R, Cardenas A, Prato MK, Bani M, et al. In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson\u2019s disease. npj Parkinson\u2019s Dis. 2023;9:114.","journal-title":"npj Parkinson\u2019s Dis"},{"key":"3505_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023;14:176.","journal-title":"Cell Death Dis"},{"key":"3505_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ DiSabato","year":"2016","unstructured":"DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. 2016;139:136\u201353.","journal-title":"J Neurochem"},{"key":"3505_CR51","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","volume":"127","author":"T Shabab","year":"2017","unstructured":"Shabab T, Khanabdali R, Moghadamtousi SZ, Kadir HA, Mohan G. Neuroinflammation pathways: A general review. Int J Neurosci. 2017;127:624\u201333.","journal-title":"Int J Neurosci"},{"key":"3505_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nri.2016.123","volume":"17","author":"B Becher","year":"2017","unstructured":"Becher B, Spath S, Goverman J. Cytokine networks in neuroinflammation. Nat Rev Immunol. 2017;17:49\u201359.","journal-title":"Nat Rev Immunol"},{"key":"3505_CR53","doi-asserted-by":"publisher","first-page":"e03505","DOI":"10.1002\/cbdv.202403505","volume":"22","author":"M Rudrapal","year":"2025","unstructured":"Rudrapal M, de Oliveira AM, de Abreu HA, Rakshit G, Tripathi MK, Khan J. Anti\u2010Inflammatory and Antioxidant Potential of Plant\u2010Derived Phenolic Acids as Triple COX, LOX, and NOX Inhibitors: A Computational Approach. Chem Biodivers. 2025;22:e03505.","journal-title":"Chem Biodivers"},{"key":"3505_CR54","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1007\/s12035-021-02318-9","volume":"58","author":"D Kumar","year":"2021","unstructured":"Kumar D, Jahan S, Khan A, Siddiqui AJ, Redhu NS, Wahajuddin, et al. Neurological manifestation of SARS-CoV-2 induced inflammation and possible therapeutic strategies against COVID-19. Mol Neurobiol. 2021;58:3417\u201334.","journal-title":"Mol Neurobiol"},{"key":"3505_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.54117\/sjmams.v3i1.13","volume":"3","author":"RC Iwu","year":"2024","unstructured":"Iwu RC, Amie DC, Eduwa OA, Sanusi-Borokini MA, Augustine FA, Zakari AO. Prevalence of pelvic inflammatory disease among women of reproductive age attending Gynaecology Clinic at Lagos State University Teaching Hospital, Ikeja, Lagos. Scicom J Med Appl Med Sci. 2024;3:45\u201350.","journal-title":"Scicom J Med Appl Med Sci"},{"key":"3505_CR56","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s13311-015-0385-3","volume":"12","author":"RM Ransohoff","year":"2015","unstructured":"Ransohoff RM, Schafer D, Vincent A, Blach\u00e8re NE, Bar-Or A. Neuroinflammation: ways in which the immune system affects the brain. Neurotherapeutics. 2015;12:896\u2013909.","journal-title":"Neurotherapeutics"},{"key":"3505_CR57","doi-asserted-by":"publisher","first-page":"239821281990108","DOI":"10.1177\/2398212819901082","volume":"4","author":"C N\u00ed Chasaide","year":"2020","unstructured":"N\u00ed Chasaide C, Lynch MA. The role of the immune system in driving neuroinflammation. Brain Neurosci Adv. 2020;4:2398212819901082.","journal-title":"Brain Neurosci Adv"},{"key":"3505_CR58","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/imm.12163","volume":"141","author":"L Peferoen","year":"2014","unstructured":"Peferoen L, Kipp M, van der Valk P, van Noort JM, Amor S. Oligodendrocyte\u2010microglia cross\u2010talk in the central nervous system. Immunology. 2014;141:302\u201313.","journal-title":"Immunology"},{"key":"3505_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9999146","volume":"2021","author":"R K\u00f6lliker-Frers","year":"2021","unstructured":"K\u00f6lliker-Frers R, Udovin L, Otero-Losada M, Kobiec T, Herrera MI, Palacios J, et al. Neuroinflammation: An integrating overview of reactive\u2010Neuroimmune cell interactions in health and disease. Mediators Inflamm. 2021;2021:9999146.","journal-title":"Mediators Inflamm"},{"key":"3505_CR60","doi-asserted-by":"publisher","first-page":"R506","DOI":"10.1016\/j.cub.2008.04.047","volume":"18","author":"D Soulet","year":"2008","unstructured":"Soulet D, Rivest S. Microglia. Curr Biol. 2008;18:R506\u2013R508.","journal-title":"Curr Biol"},{"key":"3505_CR61","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"key":"3505_CR62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh S-H. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9:42.","journal-title":"Transl Neurodegener"},{"key":"3505_CR63","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1016\/j.febslet.2011.08.033","volume":"585","author":"MB Graeber","year":"2011","unstructured":"Graeber MB, Li W, Rodriguez ML. Role of microglia in CNS inflammation. FEBS Lett. 2011;585:3798\u2013805.","journal-title":"FEBS Lett"},{"key":"3505_CR64","unstructured":"Microglia-mediated neuroinflammation in neurodegenerative diseases. Proceedings of the Seminars in cell & developmental biology 2019. Elsevier."},{"key":"3505_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.54117\/sjmams.v1i1.1","volume":"1","author":"BO Adetuyi","year":"2021","unstructured":"Adetuyi BO, Toloyai P-EY, Ojugbeli ET, Oyebanjo OT, Adetuyi OA, Uche CZ, et al. Neurorestorative roles of microgliosis and astrogliosis in neuroinflammation and neurodegeneration. Scicom J Med Appl Med Sci. 2021;1:1\u20135.","journal-title":"Scicom J Med Appl Med Sci"},{"key":"3505_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G. The role of neuroinflammation in neurodegenerative diseases: Current understanding and future therapeutic targets. Front Aging Neurosci. 2024;16:1347987.","journal-title":"Front Aging Neurosci"},{"key":"3505_CR67","first-page":"1003","volume":"1","author":"D Kempuraj","year":"2016","unstructured":"Kempuraj D, Thangavel R, Natteru P, Selvakumar G, Saeed D, Zahoor H, et al. Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine. 2016;1:1003.","journal-title":"J Neurol Neurosurg Spine"},{"key":"3505_CR68","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353:777\u201383.","journal-title":"Science"},{"key":"3505_CR69","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1007\/s11010-021-04198-y","volume":"476","author":"EA Bhat","year":"2021","unstructured":"Bhat EA, Sajjad N, Banawas S, Khan J. Human CALHM5: Insight in large pore lipid gating ATP channel and associated neurological pathologies. Mol Cell Biochem. 2021;476:3711\u20138.","journal-title":"Mol Cell Biochem"},{"key":"3505_CR70","doi-asserted-by":"publisher","first-page":"S369","DOI":"10.3233\/JAD-2010-100543","volume":"20","author":"M Di Filippo","year":"2010","unstructured":"Di Filippo M, Chiasserini D, Tozzi A, Picconi B, Calabresi P. Mitochondria and the link between neuroinflammation and neurodegeneration. J Alzheimer\u2019s Dis. 2010;20:S369\u2013S379.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"3505_CR71","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases. Mol Med Rep. 2016;13:3391\u20136.","journal-title":"Mol Med Rep"},{"key":"3505_CR72","doi-asserted-by":"publisher","first-page":"11792","DOI":"10.1523\/JNEUROSCI.3588-08.2008","volume":"28","author":"RJ Miller","year":"2008","unstructured":"Miller RJ, Rostene W, Apartis E, Banisadr G, Biber K, Milligan ED, et al. Chemokine action in the nervous system. J Neurosci. 2008;28:11792\u20135.","journal-title":"J Neurosci"},{"key":"3505_CR73","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-981-99-3848-3_8","volume-title":"Applications of Stem Cells and derived Exosomes in Neurodegenerative Disorders","author":"J Khan","year":"2023","unstructured":"Khan J, Tatli II. Stem cells vs exosomes: Promising therapeutic approach and biomarkers agent against neurodegenerative disorders. Applications of Stem Cells and derived Exosomes in Neurodegenerative Disorders. Springer; 2023. p. 169\u201391."},{"key":"3505_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105493","volume":"159","author":"TJ LaRocca","year":"2021","unstructured":"LaRocca TJ, Cavalier AN, Roberts CM, Lemieux MR, Ramesh P, Garcia MA, et al. Amyloid beta acts synergistically as a pro-inflammatory cytokine. Neurobiol Dis. 2021;159:105493.","journal-title":"Neurobiol Dis"},{"key":"3505_CR75","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"3505_CR76","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12987-022-00367-3","volume":"19","author":"F Khodadadei","year":"2022","unstructured":"Khodadadei F, Arshad R, Morales DM, Gluski J, Marupudi NI, McAllister JP, et al. The effect of A1 and A2 reactive astrocyte expression on hydrocephalus shunt failure. Fluids Barriers CNS. 2022;19:78.","journal-title":"Fluids Barriers CNS"},{"key":"3505_CR77","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","volume":"23","author":"M Colonna","year":"2023","unstructured":"Colonna M. The biology of TREM receptors. Nat Rev Immunol. 2023;23:580\u201394.","journal-title":"Nat Rev Immunol"},{"key":"3505_CR78","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","volume":"164","author":"A Bouchon","year":"2000","unstructured":"Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164:4991\u20135.","journal-title":"J Immunol"},{"key":"3505_CR79","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.jmb.2017.04.004","volume":"429","author":"DL Kober","year":"2017","unstructured":"Kober DL, Brett TJ. TREM2-ligand interactions in health and disease. J Mol Biol. 2017;429:1607\u201329.","journal-title":"J Mol Biol"},{"key":"3505_CR80","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nri1106","volume":"3","author":"M Colonna","year":"2003","unstructured":"Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol. 2003;3:445\u201353.","journal-title":"Nat Rev Immunol"},{"key":"3505_CR81","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","volume":"13","author":"M Gratuze","year":"2018","unstructured":"Gratuze M, Leyns CE, Holtzman DM. New insights into the role of TREM2 in Alzheimer\u2019s disease. Mol Neurodegener. 2018;13:66.","journal-title":"Mol Neurodegener"},{"key":"3505_CR82","doi-asserted-by":"publisher","first-page":"115218","DOI":"10.1016\/j.biopha.2023.115218","volume":"165","author":"Y Li","year":"2023","unstructured":"Li Y, Xu H, Wang H, Yang K, Luan J, Wang S. TREM2: Potential therapeutic targeting of microglia for Alzheimer\u2019s disease. Biomed Pharmacother. 2023;165:115218.","journal-title":"Biomed Pharmacother"},{"key":"3505_CR83","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","volume":"34","author":"P Forabosco","year":"2013","unstructured":"Forabosco P, Ramasamy A, Trabzuni D, Walker R, Smith C, Bras J, et al. Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging. 2013;34:2699\u2013714.","journal-title":"Neurobiol Aging"},{"key":"3505_CR84","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/bpa.12190","volume":"25","author":"LF Lue","year":"2015","unstructured":"Lue LF, Schmitz CT, Serrano G, Sue LI, Beach TG, Walker DG. TREM 2 protein expression changes correlate with A lzheimer\u2019s disease neurodegenerative pathologies in post\u2010mortem temporal cortices. Brain Pathol. 2015;25:469\u201380.","journal-title":"Brain Pathol"},{"key":"3505_CR85","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1007\/s12035-015-9416-7","volume":"53","author":"G Liu","year":"2016","unstructured":"Liu G, Liu Y, Jiang Q, Jiang Y, Feng R, Zhang L, et al. Convergent genetic and expression datasets highlight TREM2 in Parkinson\u2019s disease susceptibility. Mol Neurobiol. 2016;53:4931\u20138.","journal-title":"Mol Neurobiol"},{"key":"3505_CR86","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/neu.2016.4401","volume":"34","author":"M Saber","year":"2017","unstructured":"Saber M, Kokiko-Cochran O, Puntambekar SS, Lathia JD, Lamb BT. Triggering receptor expressed on myeloid cells 2 deficiency alters acute macrophage distribution and improves recovery after traumatic brain injury. J Neurotrauma. 2017;34:423\u201335.","journal-title":"J Neurotrauma"},{"key":"3505_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-016-0202-9","volume":"8","author":"N Celarain","year":"2016","unstructured":"Celarain N, S\u00e1nchez-Ruiz de Gordoa J, Zelaya MV, Rold\u00e1n M, Larumbe R, Pulido L, et al. TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer\u2019s disease hippocampus. Clin Epigenetics. 2016;8:1\u201310.","journal-title":"Clin Epigenetics"},{"key":"3505_CR88","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.expneurol.2018.01.016","volume":"302","author":"M Ren","year":"2018","unstructured":"Ren M, Guo Y, Wei X, Yan S, Qin Y, Zhang X, et al. TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson\u2019s disease. Exp Neurol. 2018;302:205\u201313.","journal-title":"Exp Neurol"},{"key":"3505_CR89","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.biopsych.2017.10.007","volume":"83","author":"C Condello","year":"2018","unstructured":"Condello C, Yuan P, Grutzendler J. Microglia-mediated neuroprotection, TREM2, and Alzheimer\u2019s disease: Evidence from optical imaging. Biol Psychiatry. 2018;83:377\u201387.","journal-title":"Biol Psychiatry"},{"key":"3505_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02741-w","volume":"20","author":"J Xu","year":"2023","unstructured":"Xu J, Zhang L, Li M, He X, Luo J, Wu R, et al. TREM2 mediates physical exercise-promoted neural functional recovery in rats with ischemic stroke via microglia-promoted white matter repair. J Neuroinflammation. 2023;20:50.","journal-title":"J Neuroinflammation"},{"key":"3505_CR91","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/pharmaceutics14061123","volume":"14","author":"S Jahan","year":"2022","unstructured":"Jahan S, Redhu NS, Siddiqui AJ, Iqbal D, Khan J, Banawas S, et al. Nobiletin as a neuroprotectant against NMDA receptors: an in silico approach. Pharmaceutics. 2022;14:1123.","journal-title":"Pharmaceutics"},{"key":"3505_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2020.9451","volume":"21","author":"R Li","year":"2021","unstructured":"Li R, Wang X, He P. The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer\u2019s disease: A systematic review and meta\u2011analysis. Exp Ther Med. 2021;21:1\u20131.","journal-title":"Exp Ther Med"},{"key":"3505_CR93","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/cells10020321","volume":"10","author":"F Xue","year":"2021","unstructured":"Xue F, Du H. TREM2 mediates microglial anti-inflammatory activations in Alzheimer\u2019s disease: lessons learned from transcriptomics. Cells. 2021;10:321.","journal-title":"Cells"},{"key":"3505_CR94","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/cbin.10975","volume":"43","author":"C Li","year":"2019","unstructured":"Li C, Zhao B, Lin C, Gong Z, An X. TREM2 inhibits inflammatory responses in mouse microglia by suppressing the PI3K\/NF\u2010\u03baB signaling. Cell Biol Int. 2019;43:360\u201372.","journal-title":"Cell Biol Int"},{"key":"3505_CR95","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/ALN.0000000000001628","volume":"127","author":"Q Zhai","year":"2017","unstructured":"Zhai Q, Li F, Chen X, Jia J, Sun S, Zhou D, et al. Triggering receptor expressed on myeloid cells 2, a novel regulator of immunocyte phenotypes, confers neuroprotection by relieving neuroinflammation. Anesthesiology. 2017;127:98\u2013110.","journal-title":"Anesthesiology"},{"key":"3505_CR96","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3892\/mmr.2017.7212","volume":"16","author":"P Ye","year":"2017","unstructured":"Ye P, Xu D, Xu J, Liu G, Huang S, Zhang W, et al. TREM-2 negatively regulates LPS-mediated inflammatory response in rat bone marrow-derived MSCs. Mol Med Rep. 2017;16:4777\u201383.","journal-title":"Mol Med Rep"},{"key":"3505_CR97","doi-asserted-by":"publisher","first-page":"5926","DOI":"10.4049\/jimmunol.1001591","volume":"185","author":"B Lee","year":"2010","unstructured":"Lee B, Kim T-H, Jun J-B, Yoo D-H, Woo J-H, Choi SJ, et al. Direct inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1\u03b2. J Immunol. 2010;185:5926\u201334.","journal-title":"J Immunol"},{"key":"3505_CR98","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","volume":"177","author":"IR Turnbull","year":"2006","unstructured":"Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, et al. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol. 2006;177:3520\u20134.","journal-title":"J Immunol"},{"key":"3505_CR99","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2016.03.004","volume":"42","author":"H Zheng","year":"2016","unstructured":"Zheng H, Liu C-C, Atagi Y, Chen X-F, Jia L, Yang L, et al. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Neurobiol Aging. 2016;42:132\u201341.","journal-title":"Neurobiol Aging"},{"key":"3505_CR100","doi-asserted-by":"publisher","first-page":"e0150211","DOI":"10.1371\/journal.pone.0150211","volume":"11","author":"S Bhattacharjee","year":"2016","unstructured":"Bhattacharjee S, Zhao Y, Dua P, Rogaev EI, Lukiw WJ. microRNA-34a-mediated down-regulation of the microglial-enriched triggering receptor and phagocytosis-sensor TREM2 in age-related macular degeneration. PLoS ONE. 2016;11:e0150211.","journal-title":"PLoS ONE"},{"key":"3505_CR101","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/glia.22966","volume":"64","author":"K Bisht","year":"2016","unstructured":"Bisht K, Sharma KP, Lecours C, Gabriela S\u00e1nchez M, El Hajj H, Milior G, et al. Dark microglia: a new phenotype predominantly associated with pathological states. Glia. 2016;64:826\u201339.","journal-title":"Glia"},{"key":"3505_CR102","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1038\/npp.2014.164","volume":"39","author":"T Jiang","year":"2014","unstructured":"Jiang T, Tan L, Zhu X-C, Zhang Q-Q, Cao L, Tan M-S, et al. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology. 2014;39:2949\u201362.","journal-title":"Neuropsychopharmacology"},{"key":"3505_CR103","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1194\/jlr.M400486-JLR200","volume":"46","author":"RM Lane","year":"2005","unstructured":"Lane RM, Farlow MR. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer\u2019s disease. J Lipid Res. 2005;46:949\u201368.","journal-title":"J Lipid Res"},{"key":"3505_CR104","doi-asserted-by":"publisher","first-page":"107691","DOI":"10.1016\/j.jbc.2024.107691","volume":"300","author":"IO McMillan","year":"2024","unstructured":"McMillan IO, Liang L, Su G, Song X, Drago K, Yang H, et al. TREM2 on microglia cell surface binds to and forms functional binary complexes with heparan sulfate modified with 6-O-sulfation and iduronic acid. J Biol Chem. 2024;300:107691.","journal-title":"J Biol Chem"},{"key":"3505_CR105","doi-asserted-by":"publisher","first-page":"e00018","DOI":"10.1097\/IN9.0000000000000018","volume":"5","author":"J-HJ Yen","year":"2023","unstructured":"Yen J-HJ, Yu I-CI. The role of ApoE-mediated microglial lipid metabolism in brain aging and disease. Immunometabolism. 2023;5:e00018.","journal-title":"Immunometabolism"},{"key":"3505_CR106","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00001756-199803090-00010","volume":"9","author":"DT Laskowitz","year":"1998","unstructured":"Laskowitz DT, Matthew WD, Bennett ER, Schmechel D, Herbstreith MH, Goel S, et al. Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. Neuroreport. 1998;9:615\u20138.","journal-title":"Neuroreport"},{"key":"3505_CR107","doi-asserted-by":"publisher","first-page":"48529","DOI":"10.1074\/jbc.M306923200","volume":"278","author":"JR Lynch","year":"2003","unstructured":"Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, et al. APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem. 2003;278:48529\u201333.","journal-title":"J Biol Chem"},{"key":"3505_CR108","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","volume":"30","author":"MP Vitek","year":"2009","unstructured":"Vitek MP, Brown CM, Colton CA. APOE genotype-specific differences in the innate immune response. Neurobiol Aging. 2009;30:1350\u201360.","journal-title":"Neurobiol Aging"},{"key":"3505_CR109","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1515\/tnsci-2022-0218","volume":"13","author":"Z Mai","year":"2022","unstructured":"Mai Z, Wei W, Yu H, Chen Y, Wang Y, Ding Y. Molecular recognition of the interaction between ApoE and the TREM2 protein. Transl Neurosci. 2022;13:93\u2013103.","journal-title":"Transl Neurosci"},{"key":"3505_CR110","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1523\/JNEUROSCI.2994-18.2019","volume":"39","author":"Y-WA Huang","year":"2019","unstructured":"Huang Y-WA, Zhou B, Nabet AM, Wernig M, S\u00fcdhof TC. Differential signaling mediated by ApoE2, ApoE3, and ApoE4 in human neurons parallels Alzheimer\u2019s disease risk. J Neurosci. 2019;39:7408\u201327.","journal-title":"J Neurosci"},{"key":"3505_CR111","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809027","volume":"10","author":"CB Lessard","year":"2018","unstructured":"Lessard CB, Malnik SL, Zhou Y, Ladd TB, Cruz PE, Ran Y, et al. High\u2010affinity interactions and signal transduction between A\u03b2 oligomers and TREM 2. EMBO Mol Med. 2018;10:e9027.","journal-title":"EMBO Mol Med"},{"key":"3505_CR112","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, et al. TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and-independent pathways. Cell. 2022;185:4153\u201369. e4119.","journal-title":"Cell"},{"key":"3505_CR113","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1007\/s12035-023-03217-x","volume":"60","author":"X Peng","year":"2023","unstructured":"Peng X, Guo H, Zhang X, Yang Z, Ruganzu JB, Yang Z, et al. TREM2 inhibits tau hyperphosphorylation and neuronal apoptosis via the PI3K\/Akt\/GSK-3\u03b2 signaling pathway in vivo and in vitro. Mol Neurobiol. 2023;60:2470\u201385.","journal-title":"Mol Neurobiol"},{"key":"3505_CR114","doi-asserted-by":"publisher","first-page":"107874","DOI":"10.1016\/j.jbc.2024.107874","volume":"300","author":"D Lin","year":"2024","unstructured":"Lin D, Kaye S, Chen M, Lyanna A, Ye L, Hammond LA, et al. Transcriptome and proteome profiling reveals TREM2-dependent and-independent glial response and metabolic perturbation in an Alzheimer\u2019s mouse model. J Biol Chem. 2024;300:107874.","journal-title":"J Biol Chem"},{"key":"3505_CR115","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/s41380-019-0396-2","volume":"24","author":"MG Sharoar","year":"2019","unstructured":"Sharoar MG, Hu X, Ma X-M, Zhu X, Yan R. Sequential formation of different layers of dystrophic neurites in Alzheimer\u2019s brains. Mol Psychiatry. 2019;24:1369\u201382.","journal-title":"Mol Psychiatry"},{"key":"3505_CR116","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","volume":"103","author":"A Griciuc","year":"2019","unstructured":"Griciuc A, Patel S, Federico AN, Choi SH, Innes BJ, Oram MK, et al. TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease. Neuron. 2019;103:820\u201335. e827.","journal-title":"Neuron"},{"key":"3505_CR117","doi-asserted-by":"publisher","first-page":"20862","DOI":"10.18632\/aging.104104","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lin Y, Wang L, Zhan H, Luo X, Zeng Y, et al. TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K\/AKT\/FoxO3a signaling pathway in Alzheimer\u2019s disease mice. Aging. 2020;12:20862.","journal-title":"Aging"},{"key":"3505_CR118","doi-asserted-by":"publisher","first-page":"e2111","DOI":"10.1038\/cddis.2015.403","volume":"7","author":"T Das","year":"2016","unstructured":"Das T, Suman S, Alatassi H, Ankem M, Damodaran C. Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer. Cell Death Dis. 2016;7:e2111.","journal-title":"Cell Death Dis"},{"key":"3505_CR119","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00018-023-04755-2","volume":"80","author":"M Omorou","year":"2023","unstructured":"Omorou M, Huang Y, Gao M, Mu C, Xu W, Han Y, et al. The forkhead box O3 (FOXO3): a key player in the regulation of ischemia and reperfusion injury. Cell Mol Life Sci. 2023;80:102.","journal-title":"Cell Mol Life Sci"},{"key":"3505_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.555175","volume":"8","author":"Y Deng","year":"2021","unstructured":"Deng Y, Ma G, Gao F, Sun X, Liu L, Mo D, et al. SOX9 knockdown-mediated FOXO3 downregulation confers neuroprotection against ischemic brain injury. Front Cell Dev Biol. 2021;8:555175.","journal-title":"Front Cell Dev Biol"},{"key":"3505_CR121","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s12276-022-00790-4","volume":"54","author":"L Meng","year":"2022","unstructured":"Meng L, Feng B, Luan L, Fang Z, Zhao G. MeCP2 inhibits ischemic neuronal injury by enhancing methylation of the FOXO3a promoter to repress the SPRY2-ZEB1 axis. Exp Mol Med. 2022;54:1076\u201385.","journal-title":"Exp Mol Med"},{"key":"3505_CR122","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molimm.2021.12.018","volume":"142","author":"JB Ruganzu","year":"2022","unstructured":"Ruganzu JB, Peng X, He Y, Wu X, Zheng Q, Ding B, et al. Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer\u2019s disease. Mol Immunol. 2022;142:22\u201336.","journal-title":"Mol Immunol"},{"key":"3505_CR123","doi-asserted-by":"publisher","first-page":"113820","DOI":"10.1016\/j.physbeh.2022.113820","volume":"251","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liu Y, Wang X, Wang D, Wu H, Chen H, et al. Treadmill exercise improve recognition memory by TREM2 pathway to inhibit hippocampal microglial activation and neuroinflammation in Alzheimer\u2019s disease model. Physiol Behav. 2022;251:113820.","journal-title":"Physiol Behav"},{"key":"3505_CR124","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"3505_CR125","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316.","journal-title":"N Engl J Med"},{"key":"3505_CR126","doi-asserted-by":"publisher","first-page":"106375","DOI":"10.1016\/j.isci.2023.106375","volume":"26","author":"A Iguchi","year":"2023","unstructured":"Iguchi A, Takatori S, Kimura S, Muneto H, Wang K, Etani H, et al. INPP5D modulates TREM2 loss-of-function phenotypes in a \u03b2-amyloidosis mouse model. Iscience. 2023;26:106375.","journal-title":"Iscience"},{"key":"3505_CR127","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CE Leyns","year":"2017","unstructured":"Leyns CE, Ulrich JD, Finn MB, Stewart FR, Koscal LJ, Remolina Serrano J, et al. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci. 2017;114:11524\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"3505_CR128","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"S-H Lee","year":"2021","unstructured":"Lee S-H, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, et al. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron. 2021;109:1283\u2013301.e1286.","journal-title":"Neuron"},{"key":"3505_CR129","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/ijbs.57078","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H, et al. Interaction between A\u03b2 and tau in the pathogenesis of Alzheimer\u2019s disease. Int J Biol Sci. 2021;17:2181.","journal-title":"Int J Biol Sci"},{"key":"3505_CR130","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220654","volume":"220","author":"N Jain","year":"2022","unstructured":"Jain N, Lewis CA, Ulrich JD, Holtzman DM. Chronic TREM2 activation exacerbates A\u03b2-associated tau seeding and spreading. J Exp Med. 2022;220:e20220654.","journal-title":"J Exp Med"},{"key":"3505_CR131","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-022-00562-8","volume":"17","author":"B Zhu","year":"2022","unstructured":"Zhu B, Liu Y, Hwang S, Archuleta K, Huang H, Campos A, et al. Trem2 deletion enhances tau dispersion and pathology through microglia exosomes. Mol Neurodegener. 2022;17:58.","journal-title":"Mol Neurodegener"},{"key":"3505_CR132","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CE Leyns","year":"2019","unstructured":"Leyns CE, Gratuze M, Narasimhan S, Jain N, Koscal LJ, Jiang H, et al. TREM2 function impedes tau seeding in neuritic plaques. Nat Neurosci. 2019;22:1217\u201322.","journal-title":"Nat Neurosci"},{"key":"3505_CR133","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuron.2022.10.022","volume":"111","author":"M Gratuze","year":"2023","unstructured":"Gratuze M, Schlachetzki JC, Albanus RDO, Jain N, Novotny B, Brase L, et al. TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4. Neuron. 2023;111:202\u201319.e207.","journal-title":"Neuron"},{"key":"3505_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-66211-w","volume":"14","author":"F Nabizadeh","year":"2024","unstructured":"Nabizadeh F, Seyedmirzaei H, Karami S. Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer\u2019s disease: A longitudinal study. Sci Rep. 2024;14:15318.","journal-title":"Sci Rep"},{"key":"3505_CR135","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.16273","volume":"169","author":"YC Wang","year":"2025","unstructured":"Wang YC, Huang LY, Guo HH, Liu M, Zhang YY, Zhang ZQ, et al. Higher CSF sTREM2 attenuates APOE \u03b54\u2010related risk for amyloid pathology in cognitively intact adults: The CABLE study. J Neurochem. 2025;169:e16273.","journal-title":"J Neurochem"},{"key":"3505_CR136","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212479","volume":"219","author":"N Zhao","year":"2022","unstructured":"Zhao N, Qiao W, Li F, Ren Y, Zheng J, Martens YA, et al. Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia. J Exp Med. 2022;219:e20212479.","journal-title":"J Exp Med"},{"key":"3505_CR137","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-022-00542-y","volume":"17","author":"R-Y Li","year":"2022","unstructured":"Li R-Y, Qin Q, Yang H-C, Wang Y-Y, Mi Y-X, Yin Y-S, et al. TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Mol Neurodegener. 2022;17:40.","journal-title":"Mol Neurodegener"},{"key":"3505_CR138","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70338","volume":"31","author":"C Zhao","year":"2025","unstructured":"Zhao C, Qi W, Lv X, Gao X, Liu C, Zheng S. Elucidating the Role of Trem2 in Lipid Metabolism and Neuroinflammation. CNS Neurosci Ther. 2025;31:e70338.","journal-title":"CNS Neurosci Ther"},{"key":"3505_CR139","doi-asserted-by":"publisher","first-page":"115962","DOI":"10.1016\/j.biopha.2023.115962","volume":"170","author":"W Wei","year":"2024","unstructured":"Wei W, Zhang L, Xin W, Pan Y, Tatenhorst L, Hao Z, et al. TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury. Biomed Pharmacother. 2024;170:115962.","journal-title":"Biomed Pharmacother"},{"key":"3505_CR140","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, Lin K, Van Lengerich B, Lianoglou S, Przybyla L, Davis SS, et al. TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron. 2020;105:837\u201354.e839.","journal-title":"Neuron"},{"key":"3505_CR141","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.arr.2019.01.012","volume":"50","author":"JY Vargas","year":"2019","unstructured":"Vargas JY, Grudina C, Zurzolo C. The prion-like spreading of \u03b1-synuclein: From in vitro to in vivo models of Parkinson\u2019s disease. Ageing Res Rev. 2019;50:89\u2013101.","journal-title":"Ageing Res Rev"},{"key":"3505_CR142","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1096\/fj.03-0338rev","volume":"18","author":"A Recchia","year":"2004","unstructured":"Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti P. \u03b1\u2010Synuclein and Parkinson\u2019s disease. FASEB J. 2004;18:617\u201326.","journal-title":"FASEB J"},{"key":"3505_CR143","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrn1199","volume":"4","author":"E Maries","year":"2003","unstructured":"Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K. The role of \u03b1-synuclein in Parkinson\u2019s disease: insights from animal models. Nat Rev Neurosci. 2003;4:727\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"3505_CR144","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L. \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2:a009399.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3505_CR145","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3389\/fneur.2018.00860","volume":"9","author":"P Troncoso-Escudero","year":"2018","unstructured":"Troncoso-Escudero P, Parra A, Nassif M, Vidal RL. Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson\u2019s Disease. Front Neurol. 2018;9:860.","journal-title":"Front Neurol"},{"key":"3505_CR146","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.3390\/ijms24065792","volume":"24","author":"C Castillo-Rangel","year":"2023","unstructured":"Castillo-Rangel C, Marin G, Hernandez-Contreras KA, Vichi-Ramirez MM, Zarate-Calderon C, Torres-Pineda O, et al. Neuroinflammation in Parkinson\u2019s disease: From gene to clinic: a systematic review. Int J Mol Sci. 2023;24:5792.","journal-title":"Int J Mol Sci"},{"key":"3505_CR147","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/B978-0-12-815950-7.00022-9","volume-title":"Genetics, Neurology, Behavior, and Diet in Parkinson\u2019s Disease","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Pratic\u00f2 D. Circadian clock disruption and neuroinflammation in Parkinson\u2019s disease: a new perspective. Genetics, Neurology, Behavior, and Diet in Parkinson\u2019s Disease. Elsevier; 2020. p. 345\u201362."},{"key":"3505_CR148","doi-asserted-by":"publisher","first-page":"12164","DOI":"10.1096\/fj.201900992R","volume":"33","author":"Y Guo","year":"2019","unstructured":"Guo Y, Wei X, Yan H, Qin Y, Yan S, Liu J, et al. TREM2 deficiency aggravates \u03b1-synuclein\u2013induced neurodegeneration and neuroinflammation in Parkinson\u2019s disease models. FASEB J. 2019;33:12164.","journal-title":"FASEB J"},{"key":"3505_CR149","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1134\/S1819712421020045","volume":"15","author":"I Babkina","year":"2021","unstructured":"Babkina I, Sergeeva S, Gorbacheva L. The role of NF-\u03baB in neuroinflammation. Neurochem J. 2021;15:114\u201328.","journal-title":"Neurochem J"},{"key":"3505_CR150","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak PP, Firestein GS. NF-\u03baB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7\u201311.","journal-title":"J Clin Invest"},{"key":"3505_CR151","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbi.2015.06.003","volume":"49","author":"Y Li","year":"2015","unstructured":"Li Y, Zhang H, Kosturakis AK, Cassidy RM, Zhang H, Kennamer-Chapman RM, et al. MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy. Brain Behav Immun. 2015;49:255\u201366.","journal-title":"Brain Behav Immun"},{"key":"3505_CR152","doi-asserted-by":"publisher","first-page":"F85","DOI":"10.1016\/S0304-419X(97)00018-8","volume":"1333","author":"A Minden","year":"1997","unstructured":"Minden A, Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 1997;1333:F85\u2013F104.","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews on Cancer"},{"key":"3505_CR153","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/0968-0004(94)90132-5","volume":"19","author":"RJ Davis","year":"1994","unstructured":"Davis RJ. MAPKs: new JNK expands the group. Trends Biochem Sci. 1994;19:470\u20133.","journal-title":"Trends Biochem Sci"},{"key":"3505_CR154","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/0092-8674(88)90076-1","volume":"54","author":"R Chiu","year":"1988","unstructured":"Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M. The c-fos protein interacts with c-JunAP-1 to stimulate transcription of AP-1 responsive genes. Cell. 1988;54:541\u201352.","journal-title":"Cell"},{"key":"3505_CR155","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1007\/s12035-023-03713-0","volume":"61","author":"P Huang","year":"2024","unstructured":"Huang P, Zhang Z, Zhang P, Feng J, Xie J, Zheng Y, et al. TREM2 deficiency aggravates NLRP3 inflammasome activation and pyroptosis in MPTP-induced Parkinson\u2019s disease mice and LPS-induced BV2 cells. Mol Neurobiol. 2024;61:2590\u2013605.","journal-title":"Mol Neurobiol"},{"key":"3505_CR156","volume":"2020","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, et al. NLRP3 inflammasome and inflammatory diseases. Oxid Med Cell Longev. 2020;2020:4063562.","journal-title":"Oxid Med Cell Longev"},{"key":"3505_CR157","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","volume":"68","author":"MT Milner","year":"2021","unstructured":"Milner MT, Maddugoda M, G\u00f6tz J, Burgener SS, Schroder K. The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer\u2019s disease. Curr Opin Immunol. 2021;68:116\u201324.","journal-title":"Curr Opin Immunol"},{"key":"3505_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109884","volume":"100","author":"H Shen","year":"2020","unstructured":"Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L, et al. New mechanism of neuroinflammation in Alzheimer\u2019s disease: the activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuro-Psychopharmacol Biol Psychiatry. 2020;100:109884.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"3505_CR159","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s12264-023-01023-y","volume":"39","author":"Q-Q Han","year":"2023","unstructured":"Han Q-Q, Le W. NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson\u2019s disease. Neurosci Bull. 2023;39:832\u201344.","journal-title":"Neurosci Bull"},{"key":"3505_CR160","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10571-017-0526-9","volume":"38","author":"S-J Yang","year":"2018","unstructured":"Yang S-J, Shao G-F, Chen J-L, Gong J. The NLRP3 inflammasome: an important driver of neuroinflammation in hemorrhagic stroke. Cell Mol Neurobiol. 2018;38:595\u2013603.","journal-title":"Cell Mol Neurobiol"},{"key":"3505_CR161","doi-asserted-by":"publisher","first-page":"892493","DOI":"10.3389\/fnagi.2022.892493","volume":"14","author":"Q Qin","year":"2022","unstructured":"Qin Q, Wan H, Wang D, Li J, Qu Y, Zhao J, et al. The association of CSF sTREM2 with cognitive decline and its dynamic change in Parkinson\u2019s disease: analysis of the PPMI cohort. Front Aging Neurosci. 2022;14:892493.","journal-title":"Front Aging Neurosci"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03505-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:03:06Z","timestamp":1781510586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03505-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":161,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3505"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03505-7","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have consented to the publication of this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors has any potential conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No AI tool was used either for editing, revising, or preparing of this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI statement"}}]}}